{
  "id": 6617552,
  "title": "FDA suggests regulatory flexibility for assessing psychedelics",
  "url": "https://urgent.news/2026/09/10/fda-suggests-regulatory-flexibility-for-assessing-psychedelics",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-10T18:09:37.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/fda-suggests-regulatory-flexibility-for-assessing-psychedelics/"
  },
  "original_language": "en",
  "account": null,
  "summary": "FDA regulators said they’re open to “innovative approaches” for studying the effects of psychedelic therapies, including the use of comparators other than placebo. The comments echo recently finalized regulatory guidance and signal ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}